BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MRC Technology Supports the ENTENTE Professional Exchange Program to Strengthen European Knowledge Transfer


4/29/2013 10:53:44 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

London, UK, 29 April 2013: MRC Technology, a technology transfer organisation, announced today its support for the ENTENTE Professional Exchange Program by becoming one of the initiative’s first hosting organisations. Considered a leading technology transfer office (TTO), MRC Technology will offer qualifying candidates a unique opportunity to develop technology transfer experience and expertise by working directly alongside MRC Technology business professionals and subject experts.

The primary focus of the exchange program is to strengthen knowledge transfer offices in universities, public research organisations, and hospitals, and to promote trans-national collaboration between industry and academia in the health sector. MRC Technology will provide participating Technology Transfer Officers with a clearer understanding of processes and priorities, and a unique insight into the organisation’s business culture and approach. In looking to build stronger relationships between TTOs and with industry, the initiative will offer candidates access to MRC Technology’s extensive drug development and commercialization expertise with the potential for future collaborations.

“The ENTENTE consortium would like to express its gratitude and thanks to MRC Technology for supporting the TTO development program,” commented Karine Baudin, Coordinator of ENTENTE. “Their willingness to share knowledge, expertise and time is an example of true professionalism and reinforces our joint desire to move healthcare forward. We hope this is the first step in a long term, sustainable initiative.”

Mike Johnson, Director of Corporate Partnerships at MRC Technology added, “We are very pleased to be contributing to this program. MRC Technology has a wealth of in-house expertise and has achieved considerable project success - we look forward to passing on our experience in translational research and technology transfer. The program opens up and adds strength to the TTO network which ultimately will help bring new medicines to patients faster.”

MRC Technology joins Ascenion (Germany), Bergen Teknologioverføring AS (Norway), Inserm Transfert (France) and Interface Entreprises-Université de Liège (Belgium) as the first hosting organizations to receive TTO candidates.

For more information about the program please visit: http://entente-health.eu/

Contacts:

MRC Technology

Suzy Hargreaves

Marketing & Communications Officer

E-mail: shargreaves@tech.mrc.ac.uk

Phone: +44 (0)20 7391 2798

Media contact

Sarah Jeffery

Zyme Communications

E-mail: sarah.jeffery@zymecommunications.com

Phone: +44 (0) 7771 730919

About MRC Technology

MRC Technology (www.mrctechnology.org) is a technology transfer organisation responsible for adding commercial value to cutting edge scientific discoveries through strategic patent protection, creative licensing of intellectual property (IP), partnered research or further scientific development.

As well as offering technology transfer services to the UK’s Medical Research Council the Company has recently broadened its activity to include helping other charitable and academic organisations (such as AICR) with IP management and commercial development of healthcare-related science, thus bringing valuable income back to the organisations to help fund further research.

MRC Technology also has small molecule drug discovery and therapeutic antibody facilities, providing lead-stage therapeutic assets to pharmaceutical and biotechnology companies. MRC Technology also has small molecule drug discovery and therapeutic antibody facilities, providing lead-stage therapeutic assets to pharmaceutical and biotechnology companies.

About ENTENTE

The ENTENTE project (www.entente-health.eu) was officially launched September 12th in Paris, France. ENTENTE is a coordinated action funded by the European Commission under the Health Work Programme of the 7th Framework Programme. This consortium brings together seven partners specialised in knowledge transfer from France, The United Kingdom, Belgium, and The Netherlands.

The aim of the 3-year project is to reinforce knowledge transfer offices in universities, public research organisations (PROs), hospitals and to promote industry-academia trans-national collaboration in the health sector. One of his key objectives is the Professional Exchange Programme which gives the opportunity to TTO Officers to have to have a unique experience in reknown TTOs, Pharmas and VCs Firms.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES